Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Every row

Showing 3 of 382 rows. One row per study per exposure: a study that tested two different things appears twice, once for each.

Scroll the table sideways to see every column.

Research and outcomes, 3 rows. Every row links to its source.
Exposure Question Direction Outcome measured Design People Effect size, as the source reported it Source
Antihypertensives / BP lowering Medicines Prevention Benefit
why

Individual participant data from five double-blind placebo-controlled trials, which is the strongest design in this table for this exposure.

Incident dementia over a median 4.3 years meta-analysis 28,008 Adjusted OR 0.87 (95% CI 0.75-0.99) for incident dementia European Heart Journal 2022
✓ Peer-reviewed PMID 36282295
Antihypertensives / BP lowering Medicines Prevention Benefit
why

Consistent across 14 trials (I-squared 0%) but small in absolute terms: 0.39 percentage points over about 4 years.

Incident dementia or cognitive impairment meta-analysis 96,158 OR 0.93 (95% CI 0.88-0.98); absolute risk reduction 0.39% over 4.1 years JAMA 2020
✓ Peer-reviewed PMID 32427305
Metformin / antidiabetic Medicines Prevention Benefit
why

Heterogeneity was near-total (I-squared 98.9%) and the estimate went to null in people newly diagnosed with diabetes (HR 1.01), which is where prevalent-user bias would be smallest.

Incident dementia meta-analysis 3,463,100 HR 0.76 (95% CI 0.65-0.91) vs non-users overall; HR 1.01 (0.81-1.27) in newly diagnosed diabetes Diabetes, Obesity and Metabolism 2025
✓ Peer-reviewed PMID 39780315

How this table was built, and where it is weak →